Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B1 | P14061 | 14/20 | 0.59 |
| ▸ | HSD17B2 | P37059 | 14/20 | 0.59 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | ERN1 | O75460 | 1/20 | 0.44 |
| ▸ | HSD17B14 | Q9BPX1 | 1/20 | 0.44 |
| ▸ | APP | P05067 | 1/20 | 0.41 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19608277 | 0.83 | HSD17B1 (0.59) | HSD17B1HSD17B2ESR2CYP3A4CYP2D6 | |
| SCHEMBL20056592 | 0.83 | HSD17B1 (0.68) | HSD17B1HSD17B2ESR2ERN1HSD17B14 | |
| SCHEMBL16581352 | 0.80 | HSD17B1 (0.77) | HSD17B1HSD17B2ESR2CYP3A4CYP2D6 | |
| SCHEMBL20056514 | 0.78 | HSD17B1 (0.69) | HSD17B1HSD17B2ESR2CYP3A4CYP2D6 | |
| SCHEMBL28903928 | 0.78 | HSD17B1 (0.69) | HSD17B1HSD17B2ESR2ERN1HSD17B14 | |
| SCHEMBL29904856 | 0.78 | HSD17B1 (0.69) | HSD17B1HSD17B2ESR2ERN1HSD17B14 | |
| SCHEMBL20243662 | 0.76 | PRSS1 (0.64) | — | |
| SCHEMBL272034 | 0.75 | HSD17B1 (0.68) | HSD17B1HSD17B2ESR2CYP3A4CYP2D6 | |
| SCHEMBL29696046 | 0.75 | HSD17B1 (0.68) | HSD17B1HSD17B2ESR2CYP3A4CYP2D6 | |
| SCHEMBL29429121 | 0.75 | HSD17B1 (0.68) | HSD17B1HSD17B2ESR2CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2970353-B1 | MANNOSE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS | VERTEX PHARMA (US) | 2018-04-18 | — | — | EP | disclosed |